Drugs / DPX-E7
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02865135 | Mar 2017 → Oct 2019 | anus cancer, cervical cancer, oropharyngeal carcinoma | Dana-Farber Cancer Institute | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DPX-E7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02865135 ↗ |